[HTML][HTML] Antiplatelet or Anticoagulant Therapy for Abdominal Aortic Aneurysms: Growth and Clinical Outcomes

AE Yaman, E Poyraz - Anatolian Journal of Cardiology, 2024 - ncbi.nlm.nih.gov
Background: Intraluminal thrombi in the abdominal aortic aneurysms (AAA) were
demonstrated to increase aneurysm growth. The effect of treatments on thrombus reduction …

[HTML][HTML] Effect of Antiplatelet Agents on Abdominal Aortic Aneurysm Process: A Systematic Review and Meta-Analysis

Y Yang, C Li, ZY Wu, ZG Chen, YP Diao… - Reviews in …, 2023 - imrpress.com
Background: This systematic review and meta-analysis aims to investigate whether
antiplatelet agents are associated with the reduction, expansion, and rupture of abdominal …

The role of intraluminal thrombus formation for expansion of abdominal aortic aneurysms

S Brunner-Ziegler, A Hammer, D Seidinger… - Wiener klinische …, 2015 - Springer
Background Though the pathophysiology of initiation, formation, and expansion of
abdominal aortic aneurysm (AAA) has been intensely researched, the distinct mechanisms …

[HTML][HTML] Antithrombotic therapy for aortic aneurysms: a systematic review and meta-analysis

KHF Wong, P Zlatanovic, DC Bosanquet… - European Journal of …, 2022 - Elsevier
Objectives The role of antithrombotic therapy in the management of aortic and peripheral
aneurysms is unclear. This systematic review and meta-analysis aimed to assess the impact …

Risks and benefits of antiplatelet therapy in patients with abdominal aortic aneurysm without symptomatic atherosclerotic disease: a nationwide cohort study

C Nicolajsen, M Soegaard, N Eldrup… - European Heart …, 2023 - academic.oup.com
Background Patients with abdominal aortic aneurysm (AAA) suffer a high risk of ischemic
events associated with concomitant atherosclerotic cardiovascular disease, and current …

Pharmacotherapy in clinical trials for abdominal aortic aneurysms: A systematic review and meta-analysis

Z Su, J Guo, Y Gu - Clinical and Applied Thrombosis …, 2022 - journals.sagepub.com
Objective There is no medical treatment proven to limit abdominal aortic aneurysm (AAA)
progression. This systematic review aimed to summarise available trial evidence on the …

[HTML][HTML] Anticoagulants and reduced thrombus load in abdominal aortic aneurysms assessed with three-dimensional contrast-enhanced ultrasound examination

RAC Skov, JP Eiberg, L Rouet, N Eldrup… - Journal of Vascular …, 2023 - Elsevier
Objective The relationship between intraluminal thrombus (ILT) and abdominal aortic
aneurysm (AAA) growth and rupture risk remains ambiguous. Studies have shown a limited …

[引用][C] Medical Treatment for Abdominal Aortic Aneurysms: No Good Evidence or No Good Trials?

KHF Wong, C Bicknell - European Journal of Vascular and Endovascular …, 2024 - Elsevier
In the treatment of abdominal aortic aneurysms (AAAs), medical management plays a major
role in reducing cardiovascular and peri-operative risk through blood pressure …

Effect of intraluminal thrombus on growth rate of abdominal aortic aneurysms.

A Domonkos, R Staffa, L Kubíček - International angiology: a journal …, 2018 - europepmc.org
Background Abdominal aortic aneurysm (AAA) includes a variety of morphologies with
changing properties. Growth rate is one of the most important factors directly linked to the …

[HTML][HTML] Thrombosis in the pathogenesis of abdominal aortic aneurysm

J Bontekoe, J Matsumura, B Liu - JVS-Vascular Science, 2023 - Elsevier
Abstract Background Abdominal aortic aneurysms (AAAs) are a relatively common vascular
pathology of the elderly with high morbidity potential. Irreversible degeneration of the aortic …